Serum Institute of India expects to develop Covid-19 vaccine by year-end

Poonawalla further said that till the vaccine comes, testing is the key and that is why SII has invested in MyLabs

Vaccine maker Serum Institute of India (SII) is hoping to develop a Covid-19 vaccine by year-end as it is focusing on a "good and safe" product and is not in a "rush", the company's CEO Adar Poonawalla said on Tuesday.

He was speaking during the launch of 'Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, that will automate lab processes from sample handling to preparing RT-PCR tubes.

Replying to a question about the development of the Covid-19 vaccine, Poonawalla said that by the end of 2020, the SII is hoping to have a vaccine.

"End of the year,